Beyondcell is a computational methodology for identifying tumour cell subpopulations with distinct drug responses in single-cell RNA-seq and Spatial Transcriptomics data.
I would like to know how you identify the drug perturbation (PSc) and the drug sensitivity (SSc)? I am a little confused about this, since your tool starts with these.
Thanks!
Both collections of signatures are derived from linear models, the differences being the data sources:
PSc: We mine the CLUE/LINCS drug perturbation collection. In this case, the signatures capture the transcriptomic differences between perturbed/unperturbed cells.
SSc: These are mined from multiple pharmacogenomics assays such as CTRP or GDSC. Briefly, we collect genes whose expression changes according to a cancer cell line's susceptibility to a given compound.
I would like to know how you identify the drug perturbation (PSc) and the drug sensitivity (SSc)? I am a little confused about this, since your tool starts with these. Thanks!